- Home
- ICCM vs SACH Comparison
ICCM vs SACH Comparison
Compare ICCM & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCM
- SACH
- Stock Information
- Founded
- ICCM 2006
- SACH 2010
- Country
- ICCM Israel
- SACH United States
- Employees
- ICCM N/A
- SACH N/A
- Industry
- ICCM
- SACH Real Estate Investment Trusts
- Sector
- ICCM
- SACH Real Estate
- Exchange
- ICCM Nasdaq
- SACH Nasdaq
- Market Cap
- ICCM 56.2M
- SACH 54.4M
- IPO Year
- ICCM N/A
- SACH 2017
- Fundamental
- Price
- ICCM $0.84
- SACH $1.09
- Analyst Decision
- ICCM Strong Buy
- SACH Hold
- Analyst Count
- ICCM 1
- SACH 4
- Target Price
- ICCM $2.50
- SACH $2.00
- AVG Volume (30 Days)
- ICCM 2.3M
- SACH 200.5K
- Earning Date
- ICCM 11-25-2025
- SACH 11-13-2025
- Dividend Yield
- ICCM N/A
- SACH 18.35%
- EPS Growth
- ICCM N/A
- SACH N/A
- EPS
- ICCM N/A
- SACH N/A
- Revenue
- ICCM $2,787,000.00
- SACH N/A
- Revenue This Year
- ICCM $3.95
- SACH N/A
- Revenue Next Year
- ICCM $266.15
- SACH $6.63
- P/E Ratio
- ICCM N/A
- SACH N/A
- Revenue Growth
- ICCM N/A
- SACH N/A
- 52 Week Low
- ICCM $0.53
- SACH $0.80
- 52 Week High
- ICCM $1.66
- SACH $2.46
- Technical
- Relative Strength Index (RSI)
- ICCM 36.08
- SACH 44.16
- Support Level
- ICCM $0.80
- SACH $1.06
- Resistance Level
- ICCM $0.90
- SACH $1.15
- Average True Range (ATR)
- ICCM 0.09
- SACH 0.05
- MACD
- ICCM -0.01
- SACH -0.00
- Stochastic Oscillator
- ICCM 7.49
- SACH 31.00
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
About SACH Sachem Capital Corp.
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.